Literature DB >> 28317925

Liver macrophages in tissue homeostasis and disease.

Oliver Krenkel1, Frank Tacke1.   

Abstract

Macrophages represent a key cellular component of the liver, and are essential for maintaining tissue homeostasis and ensuring rapid responses to hepatic injury. Our understanding of liver macrophages has been revolutionized by the delineation of heterogeneous subsets of these cells. Kupffer cells are a self-sustaining, liver-resident population of macrophages and can be distinguished from the monocyte-derived macrophages that rapidly accumulate in the injured liver. Specific environmental signals further determine the polarization and function of hepatic macrophages. These cells promote the restoration of tissue integrity following liver injury or infection, but they can also contribute to the progression of liver diseases, including hepatitis, fibrosis and cancer. In this Review, we highlight novel findings regarding the origin, classification and function of hepatic macrophages, and we discuss their divergent roles in the healthy and diseased liver.

Entities:  

Mesh:

Year:  2017        PMID: 28317925     DOI: 10.1038/nri.2017.11

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  188 in total

1.  The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.

Authors:  Karlin Raja Karlmark; Henning W Zimmermann; Christoph Roderburg; Nikolaus Gassler; Hermann E Wasmuth; Tom Luedde; Christian Trautwein; Frank Tacke
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

2.  Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.

Authors:  Joan Clària; Rudolf E Stauber; Minneke J Coenraad; Richard Moreau; Rajiv Jalan; Marco Pavesi; Àlex Amorós; Esther Titos; José Alcaraz-Quiles; Karl Oettl; Manuel Morales-Ruiz; Paolo Angeli; Marco Domenicali; Carlo Alessandria; Alexander Gerbes; Julia Wendon; Frederik Nevens; Jonel Trebicka; Wim Laleman; Faouzi Saliba; Tania M Welzel; Agustin Albillos; Thierry Gustot; Daniel Benten; François Durand; Pere Ginès; Mauro Bernardi; Vicente Arroyo
Journal:  Hepatology       Date:  2016-08-25       Impact factor: 17.425

3.  M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.

Authors:  Jinghong Wan; Merieme Benkdane; Fatima Teixeira-Clerc; Stéphanie Bonnafous; Alexandre Louvet; Fouad Lafdil; Françoise Pecker; Albert Tran; Philippe Gual; Ariane Mallat; Sophie Lotersztajn; Catherine Pavoine
Journal:  Hepatology       Date:  2013-11-20       Impact factor: 17.425

Review 4.  Hepatic myeloid-derived suppressor cells in cancer.

Authors:  José Medina-Echeverz; Tobias Eggert; Miaojun Han; Tim F Greten
Journal:  Cancer Immunol Immunother       Date:  2015-07-02       Impact factor: 6.968

5.  Long term intravital multiphoton microscopy imaging of immune cells in healthy and diseased liver using CXCR6.Gfp reporter mice.

Authors:  Felix Heymann; Patricia M Niemietz; Julia Peusquens; Can Ergen; Marlene Kohlhepp; Jana C Mossanen; Carlo Schneider; Michael Vogt; Rene H Tolba; Christian Trautwein; Christian Martin; Frank Tacke
Journal:  J Vis Exp       Date:  2015-03-24       Impact factor: 1.355

6.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

Review 7.  Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Herbert Tilg; Alexander R Moschen; Gyongyi Szabo
Journal:  Hepatology       Date:  2016-03-09       Impact factor: 17.425

Review 8.  Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.

Authors:  Jordi Bruix; Maria Reig; Morris Sherman
Journal:  Gastroenterology       Date:  2016-01-12       Impact factor: 22.682

9.  CCL2-CCR2 signaling promotes hepatic ischemia/reperfusion injury.

Authors:  Junbin Zhang; Peng Xu; Peng Song; Hui Wang; Yong Zhang; Qinggang Hu; Guoliang Wang; Shu Zhang; Qilin Yu; Timothy R Billiar; Congyi Wang; Jinxiang Zhang
Journal:  J Surg Res       Date:  2016-03-03       Impact factor: 2.192

10.  Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.

Authors:  Christine Bernsmeier; Oltin T Pop; Arjuna Singanayagam; Evangelos Triantafyllou; Vishal C Patel; Christopher J Weston; Stuart Curbishley; Fouzia Sadiq; Nikhil Vergis; Wafa Khamri; William Bernal; Georg Auzinger; Michael Heneghan; Yun Ma; Wayel Jassem; Nigel D Heaton; David H Adams; Alberto Quaglia; Mark R Thursz; Julia Wendon; Charalambos G Antoniades
Journal:  Gastroenterology       Date:  2014-12-03       Impact factor: 22.682

View more
  344 in total

1.  Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance.

Authors:  Jonathan J Pinney; Fátima Rivera-Escalera; Charles C Chu; Hannah E Whitehead; Karl R VanDerMeid; Ashley M Nelson; Michelle C Barbeau; Clive S Zent; Michael R Elliott
Journal:  Blood       Date:  2020-10-29       Impact factor: 22.113

2.  Decreased Macrophage Autophagy Promotes Liver Injury and Inflammation from Alcohol.

Authors:  Ghulam Ilyas; Francesca Cingolani; Enpeng Zhao; Kathryn Tanaka; Mark J Czaja
Journal:  Alcohol Clin Exp Res       Date:  2019-04-29       Impact factor: 3.455

3.  Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic type 2 inflammation.

Authors:  Zhixuan Loh; Rebecca L Fitzsimmons; Robert C Reid; Divya Ramnath; Andrew Clouston; Praveer K Gupta; Katharine M Irvine; Elizabeth E Powell; Kate Schroder; Jennifer L Stow; Matthew J Sweet; David P Fairlie; Abishek Iyer
Journal:  Br J Pharmacol       Date:  2019-08-17       Impact factor: 8.739

4.  Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.

Authors:  Yoon Mee Yang; Zhijun Wang; Michitaka Matsuda; Ekihiro Seki
Journal:  Arch Pharm Res       Date:  2021-01-24       Impact factor: 4.946

Review 5.  Macrophage-Targeted Therapeutics for Metabolic Disease.

Authors:  Kristin R Peterson; Matthew A Cottam; Arion J Kennedy; Alyssa H Hasty
Journal:  Trends Pharmacol Sci       Date:  2018-04-05       Impact factor: 14.819

6.  Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish.

Authors:  Sofia de Oliveira; Ruth A Houseright; Alyssa L Graves; Netta Golenberg; Benjamin G Korte; Veronika Miskolci; Anna Huttenlocher
Journal:  J Hepatol       Date:  2018-12-18       Impact factor: 25.083

7.  Role of Indole-3-Acetic Acid in NAFLD Amelioration After Sleeve Gastrectomy.

Authors:  Yu Wang; Geng Wang; Jie Bai; Ning Zhao; Qingbo Wang; Rui Zhou; Gang Li; Chaojie Hu; Xin Li; Kaixiong Tao; Zefeng Xia; Guobin Wang
Journal:  Obes Surg       Date:  2021-05-10       Impact factor: 4.129

8.  Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human.

Authors:  Juanjuan Zhao; Shuye Zhang; Yang Liu; Xiaomeng He; Mengmeng Qu; Gang Xu; Hongbo Wang; Man Huang; Jing Pan; Zhenwen Liu; Zhiwei Li; Lei Liu; Zheng Zhang
Journal:  Cell Discov       Date:  2020-04-28       Impact factor: 10.849

Review 9.  Current and Emerging Approaches for Nonalcoholic Steatohepatitis Treatment.

Authors:  Ming-Ming Chen; Jing-Jing Cai; Yao Yu; Zhi-Gang She; Hongliang Li
Journal:  Gene Expr       Date:  2019-04-02

10.  Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Deficiency Promotes the Ductular Reaction, Macrophage Accumulation, and Hepatic Fibrosis in the Abcb4-/- Mouse.

Authors:  Anuradha Krishnan; Tomohiro Katsumi; Maria E Guicciardi; Adiba I Azad; Nazli B Ozturk; Christy E Trussoni; Gregory J Gores
Journal:  Am J Pathol       Date:  2020-03-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.